506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of 506U78 in treating patients who have recurrent
or refractory non-Hodgkin's lymphoma or T-cell lymphoma. Drugs used in chemotherapy use
different ways to stop cancer cells from dividing so they stop growing or die